SBC37-01 MTCC 5856 PROCESS FOR THE THERAPEUTIC MANAGEMENT OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME USING BACILLUS COAGULANS SBC37-01 MTCC 5856

摘要

The present invention relates to the treatment of diarrhea predominant irritable bowel syndrome in humans comprising oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing at least 2 billion spores), with standard treatment of management in a specific manner. It shows the method for management.